Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry

Trial Profile

Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2013

At a glance

  • Drugs Infliximab (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms TREAT
  • Sponsors Centocor; Janssen Biotech
  • Most Recent Events

    • 13 Aug 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
    • 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Apr 2012 Additional lead trial centre (Janssen Biotech, Inc.) and actual patient number 6273 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top